News Daily News Women and Minorities Underrepresented in Heart Valve Trials L.A. McKeown July 27, 2023
News Conference News TVT 2023 ‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients Michael O'Riordan June 09, 2023
News Conference News TVT 2023 Solid Anchoring, Good Echo Results With Transapical TMVR at 2 Years Michael O'Riordan June 09, 2023
News Conference News TVT 2023 Surgical Outcomes After Failed TEER: More Insights, Red Flags From CUTTING-EDGE Shelley Wood June 08, 2023
News Conference News EuroPCR 2023 MITRAL at 5 Years: TMVR for MAC, Failing Devices Shows Ongoing Impact Caitlin E. Cox May 19, 2023
News Conference News EuroPCR 2023 Transcatheter MV Replacement vs Best Medical Therapy? Some Clues Shelley Wood May 17, 2023
News Conference News THT 2023 TEER or VAD/Transplant in the Advanced HF Patient With MR? Shelley Wood March 20, 2023
News Conference News HFSA 2022 GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions Michael O'Riordan October 04, 2022
News Conference News TCT 2022 Pascal TEER Device Performs Well in Patients With Complex Anatomy Yael L. Maxwell September 26, 2022
News Conference News TCT 2022 Newest MitraClip Iteration Performs Well in the Real World: EXPAND G4 Yael L. Maxwell September 23, 2022
News Conference News TCT 2022 TEER Linked to Better 1-Year Survival in Shock Patients With Significant MR Yael L. Maxwell September 17, 2022
News Conference News TCT 2022 Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID Michael O'Riordan September 17, 2022
News Daily News Black and Hispanic Patients Not Accessing High-Volume TEER Centers Michael O'Riordan July 19, 2022
News Features TVT 2022 Minorities, Poorer Patients Missing Out on Structural Heart Care Michael O'Riordan June 15, 2022
News Conference News EuroPCR 2022 MitraClip Helps for Atrial Functional MR: MITRA-TUNE Michael O'Riordan May 19, 2022
News Conference News STS 2022 CHOICE-MI: TMVR Mortality Much Lower With Newer Transseptal Devices Todd Neale February 03, 2022
News Daily News In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report Michael O'Riordan January 27, 2022
News Conference News PCR London Valves 2021 ‘Reasonable’ Results With TMVR for Mitral Regurgitation: CHOICE-MI Michael O'Riordan November 25, 2021
News Daily News Tendyne at 2 Years: Confirmed Feasibility but High Mortality With TMVR Yael L. Maxwell November 03, 2021
News Conference News TCT 2021 Failed MitraClip Is Uncommon, but Bleak When It Happens Michael O'Riordan October 08, 2021